INTRODUCTION AND AIMS:
Kidney transplantation is the best option for elderly patients with end stage renal disease. The major limitation in this group of patients is shortage of donors since kidneys from young donors are assigned to younger recipients. Spain had 43,4 donors pmp in 2016, 30% of them were aged over 70 years. Kidneys from these donors can be assigned to older patients without detriment to young recipients.Aims: To describe the outcomes of very old recipients using kidneys from very old donors. To identify clinical factors associated with worse outcomes in this population. METHODS: Retrospective analysis of clinical outcomes and pretrasplant clinical factors associated with graft and recipient survival in elderly patients (70 years) that received a kidney transplant from a very old donor (70 years) at our institution from October 2004 to December 2013 (n ¼ 155). RESULTS: Median age of donor and recipients was 77 (74-79) and 75 (73-78) years, respectively. The 3-year and 5-year patient survival was 73.1% and 67.1%, respectively. Death censored graft survival was 83.4% at year 3 and 80.8% at year 5. Median serum creatinine at year 5 was 1.55 (1.23-1.89) mg/dl, with a median eGFR of 40ml/min/ 1.73m 2 . The main identifiable cause of death was infections (34.3%), while the main cause of graft loss was recipient's death (47.1%). Acute rejection rate was 23%, with a median time to presentation of 2.2 months (75% of the episodes were in the first 6 months). History of cerebrovascular disease in the recipient was associated with an increased risk of recipient mortality (HR 5.12, p¼0.027) , while history of diabetes in the recipient was associated with increased risk of graft loss (HR 4.40, p¼0.0001) . CONCLUSIONS: Kidney transplantation from very old donors in patients over 70 years offers a survival advantage over staying on dialysis with an acceptable renal function in the mid-term. Infections are an important cause of death in this population. History of cerebrovascular disease in the recipient was associated with an increased risk of recipient mortality. History of diabetes in the recipient was associated with increased risk of graft loss. Acute rejection episodes were not associated with worse outcomes.
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INTRODUCTION AND AIMS:
Obese kidney allograft recipients have an increased risk of surgical complications, delayed graft function(DGF), prolonged hospital stay and late graft failure. However, there is lack of information regarding the effect of body mass index(BMI) variation after kidney transplantation(KT).
METHODS:
In this longitudinal study, we used data from Catalan Renal Registry including first KT recipients within 1990 and 2011. The annual change on post-transplantation BMI was calculated all patient follow-up (until December 2015). Main outcome variables were DGF, eGFR(CKD-EPI), patient and graft survival. Statistical analysis was adjusted for variables impacting on outcome. RESULTS: A total of 5,983 kidney trasnplant recipients were included. Obesity was observed in 609 patients(10.9%) at the time of transplantation. Obese patients were transplanted more recently, were younger and received kidneys from younger donors. Incidence of DGF was significantly higher in obese (40.38% vs 29.5%, P<0.001). Multivariate logistic regression model confirmed that baseline obesity was a risk factor for DGF (class I obesity: OR 1.6; 95%CI 1.3-2.1, P<0.001 and class II OR 2.2; 95%CI 1.5-3.2, P<0.001) whereas under-weight was protective (OR 0.5; 95%CI 0.3-0.8, P¼0.005). Moreover, baseline obesity was a detrimental factor concerning long-term graft survival (SHR 1.25; 95%CI 1.03-1.51, P<0.05) without any effect on patient survival (SHR 0.93 95%CI 0.74-1.17, P¼0.53). In obese patients with functioning graft, BMI loss of >7% was associated with better patient survival, and a BMI loss of >7% was associated with worse graft survival. CONCLUSIONS: Our conclusion is that BMI reduction after KT was not associated with eGFR improvement and only in those with a reduction of >7% patient survival was better with worse long-term graft survival. Sussex Kidney Unit, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom INTRODUCTION AND AIMS: Current UK guidelines for kidney donors recommend renal ultrasound (USS) for initial renal anatomical evaluation, and to proceed with differential renal function (DRF) assessment only if the disparity in length is 2cm. They also define a significant difference in DRF as >10%. DRF will influence the choice of donated kidney, usually with the lesser functioning kidney being donated. However there is no consistency in the protocols used across the UK, resulting from a lack of published evidence to guide such recommendations. This study sought to address this evidence deficit by looking at the correlation between renal size (based on USS assessment) and DRF in a single centre. METHODS: All 143 potential kidney donors over a 7 year period (between July 2009 and May 2016) who had undergone both renal USS and MAG3 scintigraphy, regardless of disparity in kidney size, were studied to compare sonographic left/right renal length discrepancy and DRF. RESULTS: All 143 patients identified had had both USS and DRF measurements, with no patients excluded on the basis of original USS findings. Of the 143 patients, 110 had a renal length difference of <1.0 cm, 29 of 1.0-1.9 cm, and 4 of 2.0 cm. The relationship between the length difference and DRF is shown in the INTRODUCTION AND AIMS:Simultaneous pancreas-kidney transplantation (SPKT) is an effective therapy to reverse metabolic abnormalities and prevent or minimize many of the secondary complications of T1DM. Significant cardiovascular and peripheral vascular disease may contraindicate transplantation. The aim of this study is to evaluate the cardiovascular morbidity of SPKT recipients at our center, divided into two groups on the basis of the presence/absence of angiographically evident coronary artery disease (CAD), as well as the presence/absence of abdominal computed tomography (CT) evident vascular disease. METHODS: Retrospective analysis of all SKPT patients at our transplant center. The comparison between subgroups of patients was performed using the Wilcoxon, Fisher exact test or t-test, Qui2, according to normality. STATA software was used and p <0.05 was considered statistically significant. RESULTS: 72 SPK recipients were included, all had T1DM. Most patients were male (64%), with a mean age of 37 years, a median time of T1DM of 25.5 years.
FP725 LACK OF DISPARITY IN RENAL LENGTH IS NOT A RELIABLE GUIDE TO NORMAL DIFFERENTIAL RENAL FUNCTION IN POTENTIAL KIDNEY DONORS
Complications of diabetes were frequent: retinopathy 100%, peripheral neuropathy 43%, dysautonomia 27.8%, peripheral arterial disease (PAD, defined by claudication or previous amputation) 22%. Most patients (89%) presented hypertenstion and 26% of these were on 3 or more antihypertensive medications. Six patients underwent a preemptive transplant, and the remaining patients presented a median time on dialysis of 2.8 years. Mean body mass index (BMI) was 23, with mean HbA1c of 8.7%, and smoking history in 43%.Coronary angiography was performed in 58 patients, identifying a lesion in 43% (n ¼ 25). Of these, 32% of patients underwent coronary intervention (7 angioplasty with stent placement and 1 bypass surgery) and the remainder were treated 
